Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 HKD | 0.00% |
|
+8.22% | -14.13% |
06-26 | Simcere Zaiming and Mabpharm Limited Announce Approval of Cetuximab Beta in China by the NMPA | CI |
06-25 | Simcere-Mabpharm Cancer Drug Gets Marketing Approval in China | MT |
Business Summary
Number of employees: 347
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monoclonal Antibody Drugs
100.0
%
| 65 | 100.0 % | 96 | 100.0 % | +48.11% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 65 | 100.0 % | 96 | 100.0 % | +48.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hao Wang
CEO | Chief Executive Officer | 55 | 19/07/18 |
Yun Feng Li
DFI | Director of Finance/CFO | 47 | 19/07/18 |
Tao Jing
BRD | Director/Board Member | 51 | 02/08/18 |
Zhuge Wenhui
SAM | Sales & Marketing | - | 31/07/18 |
Ho Yin Tsang
SEC | Corporate Secretary | 38 | 30/05/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shu Ge Jiao
CHM | Chairman | 58 | 19/07/18 |
Ho Ming Leung
BRD | Director/Board Member | 41 | 16/06/22 |
Wei Zhu Qian
FOU | Founder | 48 | 03/02/15 |
Hao Wang
CEO | Chief Executive Officer | 55 | 19/07/18 |
Yun Feng Li
DFI | Director of Finance/CFO | 47 | 19/07/18 |
Liang Zhong Guo
BRD | Director/Board Member | 58 | 09/08/18 |
Yan Yun Zhang
BRD | Director/Board Member | 68 | 09/08/18 |
Tao Jing
BRD | Director/Board Member | 51 | 02/08/18 |
Sheng Hou
BRD | Director/Board Member | 47 | 11-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,124,080,000 | 941,260,140 ( 22.82 %) | 0 | 22.82 % |
Company contact information
![address Mabpharm Limited(2181)](https://cdn.zonebourse.com/static/address/103501613.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-14.13% | 209M | |
+16.13% | 122B | |
+19.65% | 113B | |
+19.51% | 26.49B | |
-23.84% | 19.4B | |
-17.91% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- 2181 Stock
- Company Mabpharm Limited